journal article·2022-07Open access

Multiomics Analysis Identifies SOCS1 as Restraining T Cell Activation and Preventing Graft‐Versus‐Host Disease

Huidong Guo, Ruifeng Li, Ming Wang, Yingping Hou, Shuoshuo Liu, Ting Peng, Xiang‐Yu Zhao, Liming Lu, Yali Han, Yiming Shao, Ying‐Jun Chang, Cheng Li, Xiao‐Jun Huang

Advanced Science· Volume 9· Issue 21

Abstract

Abstract Graft‐versus‐host disease (GVHD) is a major life‐threatening complication of allogeneic hematopoietic stem cell transplantation (allo‐HSCT). Inflammatory signaling pathways promote T‐cell activation and are involved in the pathogenesis of GVHD. Suppressor of cytokine signaling 1 (SOCS1) is a critical negative regulator for several inflammatory cytokines. However, its regulatory role in T‐cell activation and GVHD has not been elucidated. Multiomics analysis of the transcriptome and chromatin structure of granulocyte‐colony‐stimulating‐factor (G‐CSF)‐administered hyporesponsive T cells from healthy donors reveal that G‐CSF upregulates SOCS1 by reorganizing the chromatin structure around the SOCS1 locus. Parallel in vitro and in vivo analyses demonstrate that SOCS1 is critical for restraining T cell activation. Loss of Socs1 in T cells exacerbates GVHD pathogenesis and diminishes the protective role of G‐CSF in GVHD mouse models. Further analysis shows that SOCS1 inhibits T cell activation not only by inhibiting the colony‐stimulating‐factor 3 receptor (CSF3R)/Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway, but also by restraining activation of the inflammasome signaling pathway. Moreover, high expression of SOCS1 in T cells from patients correlates with low acute GVHD occurrence after HSCT. Overall, these findings identify that SOCS1 is critical for inhibiting T cell activation and represents a potential target for the attenuation of GVHD.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cytokine Signaling Pathways and Interactions · Immune Cell Function and Interaction · T-cell and B-cell Immunology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation School of Life Sciences Peking University People's Hospital Peking University Beijing 100044 China

Peking‐Tsinghua Center for Life Sciences Peking University Beijing 100080 China

Institute for Immunology and School of Medicine Tsinghua University Beijing 100084 China

Beijing Tsinghua Changgeng Hospital Beijing 102218 China

Shanghai Institute of Immunology Shanghai Jiaotong University School of Medicine 280 South Chongqing Road Shanghai 200025 China

Shanghai Jiayin Biotechnology, Ltd. Shanghai 200092 China

Center for Statistical Science Center for Bioinformatics Peking University Beijing China

Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies (2019RU029) Chinese Academy of Medical Sciences Beijing 100730 China

Funding

National Key Research and Development Program of China · Beijing Municipal Science and Technology Commission · National Natural Science Foundation of China · Beijing Municipal Natural Science Foundation · Fundamental Research Funds for the Central Universities

References (73)

Show source-provided references
1. 10.1056/NEJMp07816610.1056/NEJMp078166 ↗
2. 10.1182/blood-2016-08-73319610.1182/blood-2016-08-733196 ↗
3. 10.1182/blood-2015-02-62778610.1182/blood-2015-02-627786 ↗
4. 10.1182/blood-2014-02-51474510.1182/blood-2014-02-514745 ↗
5. 10.1016/S2352-3026(19)30256-X10.1016/S2352-3026(19)30256-X ↗
6. Z. X.Pasquini MC http://www.cibmtr.org(accessed: 2014).
7. 10.1111/bjh.1429510.1111/bjh.14295 ↗
8. 10.1053/j.seminhematol.2005.09.00110.1053/j.seminhematol.2005.09.001 ↗
9. 10.1182/blood-2006-12-06398210.1182/blood-2006-12-063982 ↗
10. 10.1158/1078-0432.CCR-10-119810.1158/1078-0432.CCR-10-1198 ↗
11. 10.1038/nrrheum.2015.16710.1038/nrrheum.2015.167 ↗
12. 10.1182/blood-2013-12-54373610.1182/blood-2013-12-543736 ↗
13. 10.1038/ni.369110.1038/ni.3691 ↗
14. 10.1182/blood-2009-01-19717810.1182/blood-2009-01-197178 ↗
15. 10.1126/science.107154510.1126/science.1071545 ↗
16. 10.3899/jrheum.10071710.3899/jrheum.100717 ↗
17. 10.1016/S1470-2045(14)71017-410.1016/S1470-2045(14)71017-4 ↗
18. 10.1126/scitranslmed.aai826910.1126/scitranslmed.aai8269 ↗
19. 10.1038/jid.2013.47610.1038/jid.2013.476 ↗
20. 10.1016/j.ejphar.2020.17350510.1016/j.ejphar.2020.173505 ↗
21. 10.1038/s41375-020-0827-810.1038/s41375-020-0827-8 ↗
22. 10.1084/jem.2013008410.1084/jem.20130084 ↗
23. 10.1101/cshperspect.a02857110.1101/cshperspect.a028571 ↗
24. 10.1038/nri209310.1038/nri2093 ↗
25. 10.1038/s41467-018-04013-110.1038/s41467-018-04013-1 ↗
26. 10.1016/S0092-8674(00)80047-110.1016/S0092-8674(00)80047-1 ↗
27. 10.1111/j.1365-2222.2009.03217.x10.1111/j.1365-2222.2009.03217.x ↗
28. 10.1167/iovs.11-768810.1167/iovs.11-7688 ↗
29. 10.1111/sji.1247510.1111/sji.12475 ↗
30. 10.1016/j.jneuroim.2010.10.01810.1016/j.jneuroim.2010.10.018 ↗
31. 10.4049/jimmunol.175.11.708510.4049/jimmunol.175.11.7085 ↗
32. 10.1016/j.molimm.2015.12.00610.1016/j.molimm.2015.12.006 ↗
33. Jun H. X. · Haematologica · 2004 · 89 · 1517
34. 10.4049/jimmunol.130231510.4049/jimmunol.1302315 ↗
35. 10.1182/blood-2002-04-120010.1182/blood-2002-04-1200 ↗
36. 10.1182/blood-2003-08-286410.1182/blood-2003-08-2864 ↗
37. 10.1007/s11427-020-1754-610.1007/s11427-020-1754-6 ↗
38. 10.1038/s41588-019-0505-910.1038/s41588-019-0505-9 ↗
39. 10.1038/nature2236710.1038/nature22367 ↗
40. 10.1016/j.cell.2014.11.02110.1016/j.cell.2014.11.021 ↗
41. 10.1093/nar/gks39510.1093/nar/gks395 ↗
42. 10.4161/trns.2736810.4161/trns.27368 ↗
43. 10.1016/j.celrep.2017.05.01310.1016/j.celrep.2017.05.013 ↗
44. 10.1073/pnas.171401911410.1073/pnas.1714019114 ↗
45. 10.1101/gr.147652.11210.1101/gr.147652.112 ↗
46. 10.1084/jem.2011042810.1084/jem.20110428 ↗
47. 10.1016/j.trim.2009.05.00510.1016/j.trim.2009.05.005 ↗
48. 10.4049/jimmunol.178.8.505810.4049/jimmunol.178.8.5058 ↗
49. 10.3389/fimmu.2015.0018310.3389/fimmu.2015.00183 ↗
50. 10.1016/j.bbmt.2019.01.01310.1016/j.bbmt.2019.01.013 ↗
51. 10.1016/j.bbadis.2018.06.02210.1016/j.bbadis.2018.06.022 ↗
52. 10.4049/jimmunol.120230710.4049/jimmunol.1202307 ↗
53. 10.1002/ajh.2386510.1002/ajh.23865 ↗
54. 10.1186/s12967-015-0507-z10.1186/s12967-015-0507-z ↗
55. 10.1016/S1074-7613(04)00022-610.1016/S1074-7613(04)00022-6 ↗
56. 10.1182/blood-2007-03-07917810.1182/blood-2007-03-079178 ↗
57. 10.1038/ni132010.1038/ni1320 ↗
58. 10.1038/ni132110.1038/ni1321 ↗
59. 10.1016/S1074-7613(00)00078-910.1016/S1074-7613(00)00078-9 ↗
60. 10.4049/jimmunol.180.6.374610.4049/jimmunol.180.6.3746 ↗
61. 10.1016/j.it.2009.09.00910.1016/j.it.2009.09.009 ↗
62. 10.1038/s41467-020-18925-410.1038/s41467-020-18925-4 ↗
63. 10.1126/sciimmunol.abe821910.1126/sciimmunol.abe8219 ↗
64. 10.1038/s41577-019-0165-010.1038/s41577-019-0165-0 ↗
65. 10.1038/ni.338910.1038/ni.3389 ↗
66. 10.1182/blood-2009-12-25959810.1182/blood-2009-12-259598 ↗
67. 10.1186/gb-2013-14-4-r3610.1186/gb-2013-14-4-r36 ↗
68. 10.1038/nbt.162110.1038/nbt.1621 ↗
69. 10.1038/nmeth.268810.1038/nmeth.2688 ↗
70. 10.1038/nature1264410.1038/nature12644 ↗
71. 10.1038/nmeth.192310.1038/nmeth.1923 ↗
72. 10.1038/nmeth.214810.1038/nmeth.2148 ↗
73. 10.1038/s41598-020-80165-910.1038/s41598-020-80165-9 ↗